Biostar Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Biostar Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 91% to $2,384,492. The net income raised on -$5,698,385 and profit margin reached -239%. Total operating expenses were $4,479,436.
Profit Margin
| 2010 | 80.21M | 17.38M | 21.67% |
|---|---|---|---|
| 2011 | 91.96M | 12.17M | 13.24% |
| 2012 | 49.31M | -19.99M | -40.55% |
| 2013 | 52.72M | 809.04K | 1.53% |
| 2014 | 61.41M | 4.84M | 7.89% |
| 2015 | 27.12M | -25.11M | -92.57% |
| 2016 | 2.38M | -5.69M | -238.98% |
BSPM Income Statement (2010 – 2016)
| 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 2.38M | 27.12M | 61.41M | 52.72M | 49.31M | 91.96M | 80.21M |
Cost of revenue | 1.46M | 16.02M | 31.14M | 27.04M | 19.46M | 27.57M | 20.07M |
Gross profit | 915.17K | 11.10M | 30.27M | 25.68M | 29.85M | 64.38M | 60.13M |
Operating exp. | |||||||
Research and development | 1.14M | 4.02M | 2.76M | 3.22M | 4.47M | 2.32M | 0 |
Selling and marketing | 1.16M | 8.63M | 18.48M | 16.57M | 27.88M | 38.22M | 32.31M |
Total operating expenses | 4.47M | 21.97M | 28.97M | 24.60M | 41.99M | 46.22M | 36.52M |
Operating income | -3.56M | -10.87M | 2.63M | 2.42M | -21.78M | 18.15M | 23.61M |
Other income (expenses), net | 518.93K | -35.15K | 2.84M | 230.86K | 212.35K | 92.90K | 155.57K |
Income before tax | -3.04M | -23.79M | 1.53M | 2.65M | -21.57M | 18.06M | 23.45M |
Income tax expense | 2.65M | 1.31M | -3.31M | 1.84M | -1.57M | 5.89M | 6.07M |
Net income | -5.69M | -25.11M | 4.84M | 809.04K | -19.99M | 12.17M | 17.38M |
Earnings per share | |||||||
Basic EPS | -2.48 | -11.36 | 2.3 | 0.49 | -14.63 | 9.24 | 13.86 |
Diluted EPS | -2.48 | -11.36 | 2.3 | 0.49 | -14.63 | 9.24 | 13.23 |
| Data source | Data source | Data source |